ATTR Amyloidosis Patients Association | oneAMYLOIDOSISvoice
×
Or register here
Global Search

Trusted Resources: People & Places

Healthcare providers, researchers, and advocates

Back to Places / Community Organizations
ATTR Amyloidosis Patients Association

ATTR Amyloidosis Patients Association

United Kingdom
Email   Web  

The UK ATTR Amyloidosis Patients’ Association (UKATPA) was founded in 2017 by a group of UK patients with transthyretin (TTR)-type systemic amyloidosis (ATTR), supported by the consultant physicians of the UK NHS National Amyloidosis Centre.

In this exciting environment of change and optimism, our members decided to found a UK patient group dedicated to the interests of people in the UK with ATTR amyloidosis and to ensuring their participation in patient care and in disease and therapeutic research.

Our key objectives will be enhancement of clinical and basic science research into ATTR amyloidosis, facilitation of patient participation in clinical trials of new drugs for ATTR amyloidosis and expediting drug approval processes.  When new drugs for ATTR amyloidosis receive licensing approval we will aim to ensure clinically appropriate access for all UK ATTR amyloidosis patients.

Related Content

To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences.
More information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close

Community Key Collaborator

Support for this landing page is provided by an independent education grant from

Translation of this platform made possible through an independent education grant from

© 2025 rareLife solutions Inc.

To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences.
More information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close